This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gross, N. Articles by Brognara, C. B. Search for Related Content PubMed PubMed Citation Articles by Gross, N. Articles by Brognara, C. B.

Absence of Functional CD44 Hyaluronan Receptor on Human NMYC-amplified Neuroblastoma Cells¹

Onco-hematology Unit, Pediatrics, University Hospital, CHUV, 1011 Lausanne, Switzerland

CD44 represents a heterogeneous group of surface glycoproteins, involved in cell-cell and cell-matrix interactions. CD44 is the major receptor for hyaluronate (HA), a component of cell matrices, and most of CD44 known functions are attributed to its ability to recognize HA. We have recently shown that although a majority of human neuroblastomas (NBs), a childhood cancer, express high levels of CD44H, high stages and tumors with amplification of the NMYC proto-oncogene fail to express CD44. Lack of CD44 expression is strongly associated with the presence of NMYC amplification and has been further shown to represent a new feature for predicting risk of disease progression and dissemination. In the present study, we have investigated the role of CD44 expressed by NB cell lines and the possible relationship among the presence of NMYC amplification, functional expression of CD44 receptor, and tumorigenic properties of NB cells. A panel of cell lines with variable NMYC amplification and/or overexpression, as well as clonal and stable NMYC-transfected NB cells, were analyzed for CD44 expression and ability to bind HA. Our results confirmed previous observations that in NB cell lines lack of CD44 is not always related to the presence of NMYC amplification, with a number of cell lines or transfectants with both CD44 expression and NMYC amplification. However, the ability of the CD44 receptor to bind immobilized hyaluronan was restricted to CD44H⁺ cell lines without NMYC amplification (SH-EP and ACN). The HA-binding function was CD44 dependent and could be specifically blocked by an anti-CD44 antibody. No induction of functional HA binding was obtained with NMYC-amplified cell lines or NMYC transfectants, despite an induced increase of CD44 expression upon differentiation or after tentative activation of the receptor with phorbol esters. Inhibition of N-linked glycosylation with tunicamycin resulted in decreased HA binding of cells bearing an active CD44 receptor. We conclude that NMYC-amplified NB cell lines either do not express CD44 at all or express a nonfunctional receptor, whereas nonamplified cells constitutively express an active receptor. The lack of functional HA binding in NB cells might be partly due to incomplete N-glycosylation. The involvement of NMYC in the regulation of N-linked glycosylation can be suspected.

¹ This work was supported by Swiss National Scientific Foundation Grant 32-037544.93 and la fondation pour la recherche sur le cancer des enfants (FORCE).

² To whom requests for reprints should be addressed.

Received 10/18/96. Accepted 2/ 2/97.

This article has been cited by other articles:

				Y. Xie, H. Chan, J. Fan, Y. Chen, J. Young, W. Li, X. Miao, Z. Yuan, H. Wang, P. K.H. Tam, et al. Involvement of visinin-like protein-1 (VSNL-1) in regulating proliferative and invasive properties of neuroblastoma Carcinogenesis, October 1, 2007; 28(10): 2122 - 2130. [Abstract] [Full Text] [PDF]

				M. Alaminos, J. Mora, N.-K. V. Cheung, A. Smith, J. Qin, L. Chen, and W. L. Gerald Genome-wide Analysis of Gene Expression Associated with MYCN in Human Neuroblastoma Cancer Res., August 1, 2003; 63(15): 4538 - 4546. [Abstract] [Full Text] [PDF]

				M. Lastowska, C. Cullinane, S. Variend, S. Cotterill, N. Bown, S. O'Neill, K. Mazzocco, P. Roberts, J. Nicholson, C. Ellershaw, et al. Comprehensive Genetic and Histopathologic Study Reveals Three Types of Neuroblastoma Tumors J. Clin. Oncol., June 15, 2001; 19(12): 3080 - 3090. [Abstract] [Full Text] [PDF]

				V. B. Lokeshwar and M. G. Selzer Differences in Hyaluronic Acid-mediated Functions and Signaling in Arterial, Microvessel, and Vein-derived Human Endothelial Cells J. Biol. Chem., September 1, 2000; 275(36): 27641 - 27649. [Abstract] [Full Text] [PDF]